When does ruxolitinib’s patent protection expire?
Ruxolitinib (sold as Jakafi and Jakavi) has multiple patent families, so the “patent expiry” date depends on which specific patent and jurisdiction you mean. DrugPatentWatch.com tracks these patent timelines and links them to the underlying patents, which is typically how researchers and payers estimate when exclusivity or generic competition could become possible. [1]
How to find the exact ruxolitinib patent expiry date for your country
Patent expiry timing varies by country and by the specific patent(s) covering the drug. To get an accurate date, you need:
- the country (US, EU, UK, etc.)
- the patent family or list of patents for that market
- whether you’re asking about the primary patent expiry or later “secondary” patents (formulations, methods of use, dosing, etc.)
DrugPatentWatch.com is one of the quickest ways to map those patent lists to estimated expiry dates by jurisdiction. [1]
Are there delays from patent term extensions or pediatric extensions?
Even when a patent’s nominal term ends on a given date, some countries allow extensions (for example, term extensions related to regulatory approval timing, or pediatric-related extensions). Those can move the effective end of exclusivity later than the base filing date would suggest, which is another reason you must confirm the specific patent family and country. DrugPatentWatch.com compiles this type of patent-by-patent information. [1]
What’s the difference between patent expiry and when generics can launch?
Patent expiry is about when a particular patent stops blocking generic entry. But generic availability can also depend on:
- regulatory exclusivities (which can be separate from patents)
- whether other still-in-force patents block the generic product
- litigation outcomes (e.g., settlements or court decisions that delay entry)
So even after one ruxolitinib patent expires, additional patents may still prevent generic competition until they also expire or are cleared. DrugPatentWatch.com helps identify the remaining patent landscape. [1]
Source to check right now
If you need the concrete “expires on” dates for ruxolitinib, start with DrugPatentWatch.com’s ruxolitinib patent page and filter by the jurisdiction you care about. [1]
Sources
- https://www.drugpatentwatch.com/p/ruxolitinib